Live Breaking News & Updates on Patient reported outcomes

Stay informed with the latest breaking news from Patient reported outcomes on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Patient reported outcomes and stay connected to the pulse of your community

Form 10-K Jaguar Health, Inc. For: Dec 31

Form 10-K Jaguar Health, Inc. For: Dec 31
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nigeria , Brazil , Kenya , Jordan , Russia , Italy , State-of-delaware , Delaware , United-states , California , Beijing , China

AOFAS Awards More Than $250,000 in Grants to Fund Foot and Ankle Orthopaedic Research

AOFAS Awards More Than $250,000 in Grants to Fund Foot and Ankle Orthopaedic Research
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jiyong-ahn , Myles-dworkin , Christopherw-digiovanni , Gregory-waryasz , Michael-david , Jasont-bariteau , L-daniel-latt , Kurt-hofmann , Lorraine-boakye , Daniel-guss , Cesar-netto , Lew-schon

Lumicell Introduces Further Research and Insights in Fluorescence-Guided Surgery at the Society of Surgical Oncology (SSO) Annual Meeting

NEWTON, Mass., March 25, 2024--Lumicell Inc., a privately held company focused on innovative fluorescence-guided imaging technologies for cancer detection during surgery, highlights presentations from clinical studies examining the use of investigational LUMISIGHT™ (pegulicianine) in combination with Lumicell™ Direct Visualization System (DVS) at the Society of Surgical Oncology Annual Meeting in Atlanta, Georgia, March 20-23, 2024.

Atlanta , Georgia , United-states , Massachusetts , Jorge-ferrer , Barbara-smith , Irene-wapnir , Imaging-drugs-advisory-committee , Facebook , Md-anderson-cancer-center , Linkedin , Breast-program-at-massachusetts

Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India

Alcon Strengthens Leadership in IOL Innovation with the launch of the Clareon Presbyopia Correcting IOLs in India
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

India , Clareon-vivity , Clareon-iols , Alcon-vivity , Ikek-ahmed , Clin-ophthalmol , Clareon-panoptix , Linkedin , Facebook , Alcon-inc , National-institute-for-health , Utilizing-alcon

Survey uncovers several critical factors motivating physicians

Last week (February 22), it was announced a recent survey conducted jointly by Climedo and Siteworks has shed light on the perspectives of more than 65 primarily European-based study physicians.

Munich , Bayern , Germany , Veronika-schweighart , Electronic-health-records , Contract-research-organizations-cros , Case-report-forms , Patient-reported-outcomes , Contract-research-organizations , Markets-amp-regulations , Reclinical-research , Linical-development

Retrospective Claims Data and Patient Reported-Outcomes from COMMANDS Trial in Lower-Risk MDS

Amy DeZern, MD, MHS, discusses a retrospective study on healthcare claims for patients with MDS treated with luspatercept and reviews patient-reported outcomes from the COMMANDS trial.

Amy-dezern , Evolving-treatment-landscape , Myelodysplastic-syndromes , Claims-data , Patient-reported-outcomes , Mds , Mds-treatment , Myelodysplastic-syndromes-treatment , Ash-2023 , Real-world-outcomes , Luspatercept

Cogent Biosciences (COGT) Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis

Cogent Biosciences (COGT) Announces Positive Part 1b Data from SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Washington , United-states , Berlin , Germany , Frank-siebenhaar , Andrew-robbins , Head-university-outpatient-clinic , Data-monitoring-committee , Cogent-biosciences-inc , Nasdaq , Bezuclastinib-clinical-development , Institute-of-allergology

Cogent Biosciences Announces Positive Part 1b Data from

Registration-enabling SUMMIT Part 2 initiated and actively enrolling at 40 sites globally; RP2D selected at 100 mg once-daily optimized formulation based...

Berlin , Germany , Washington , United-states , Andrew-robbins , Frank-siebenhaar , Christi-waarich , Nasdaq , Data-monitoring-committee , Head-university-outpatient-clinic , Cogent-biosciences-inc , Linkedin